Literature DB >> 8227367

Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

A H Schmaier1, L D Dahl, A J Rozemuller, R A Roos, S L Wagner, R Chung, W E Van Nostrand.   

Abstract

Protease nexin-2/amyloid beta protein precursor (PN-2/A beta PP) is an abundant, secreted platelet protein which is a potent inhibitor of coagulation Factor XIa. We examined other potential anticoagulant activities of PN-2/A beta PP. Purified Kunitz protease inhibitor domain of PN-2/A beta PP and PN-2/A beta PP itself were found to prolong the coagulation time of plasma and pure Factor IXa. The Kunitz protease inhibitor domain also inhibited the ability of Factor IXa to activate Factor X. PN-2/A beta PP inhibited Factor IXa with a Ki of 7.9 to 3.9 x 10(-11) M in the absence and presence of heparin, respectively. When the second-order rate constant of PN-2/A beta PP's inhibition of Factor IXa (2.7 x 10(8) M-1min-1) was compared to that of antithrombin III (3.8 x 10(6) M-1min-1), PN-2/A beta PP was at least a 71-fold more potent inhibitor of Factor IXa than antithrombin III. PN-2/A beta PP formed a complex with Factor IXa as detected by gel filtration and ELISA. The finding that PN-2/A beta PP is a potent inhibitor of Factor IXa could help to explain the spontaneous intracerebral hemorrhages seen in patients with hereditary cerebral hemorrhage with amyloidosis Dutch-type where there is an extensive accumulation of PN-2/A beta PP in their cerebral blood vessels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227367      PMCID: PMC288440          DOI: 10.1172/JCI116863

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Haemophilia treatment in the United Kingdom from 1969 to 1974.

Authors:  R Biggs
Journal:  Br J Haematol       Date:  1977-04       Impact factor: 6.998

2.  Interaction of plasma kallikrein with the C1 inhibitor.

Authors:  I Gigli; J W Mason; R W Colman; K F Austen
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

3.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

4.  Activation of factor IX bound to cultured bovine aortic endothelial cells.

Authors:  D M Stern; M Drillings; W Kisiel; P Nawroth; H L Nossel; K S LaGamma
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

5.  The acceleration by polylysine of the activation of factor X by factor IXa.

Authors:  R L Lundblad; H R Roberts
Journal:  Thromb Res       Date:  1982-02-15       Impact factor: 3.944

6.  High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews.

Authors:  U Seligsohn
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

7.  Inhibition of human factor IXa by human antithrombin.

Authors:  J S Rosenberg; P W McKenna; R D Rosenberg
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

8.  Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.

Authors:  M J Griffith; L Breitkreutz; H Trapp; E Briet; C M Noyes; R L Lundblad; H R Roberts
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency.

Authors:  S I RAPAPORT; R R PROCTOR; M J PATCH; M YETTRA
Journal:  Blood       Date:  1961-08       Impact factor: 22.113

10.  Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.

Authors:  C F Scott; M Schapira; H L James; A B Cohen; R W Colman
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  23 in total

1.  Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

Authors:  Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh
Journal:  J Biochem       Date:  2010-07-20       Impact factor: 3.387

2.  Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis.

Authors:  Feng Xu; Judianne Davis; Jianting Miao; Mary Lou Previti; Galina Romanov; Kelly Ziegler; William E Van Nostrand
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability.

Authors:  Georgette L Suidan; Pradeep K Singh; Sunita Patel-Hett; Zu-Lin Chen; Dmitri Volfson; Hitomi Yamamoto-Imoto; Erin H Norris; Robert D Bell; Sidney Strickland
Journal:  Blood Adv       Date:  2018-05-08

4.  Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.

Authors:  Benjamin J Samelson-Jones; Jonathan D Finn; Lindsey A George; Rodney M Camire; Valder R Arruda
Journal:  JCI Insight       Date:  2019-06-20

5.  Mutation of the Kunitz-type proteinase inhibitor domain in the amyloid β-protein precursor abolishes its anti-thrombotic properties in vivo.

Authors:  Feng Xu; Judianne Davis; Michael Hoos; William E Van Nostrand
Journal:  Thromb Res       Date:  2017-05-04       Impact factor: 3.944

Review 6.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 7.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

Review 8.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

9.  Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome.

Authors:  Shinobu Kitazume; Akiomi Yoshihisa; Takayoshi Yamaki; Masayoshi Oikawa; Yuriko Tachida; Kazuko Ogawa; Rie Imamaki; Yoshiaki Hagiwara; Noriaki Kinoshita; Yasuchika Takeishi; Katsutoshi Furukawa; Naoki Tomita; Hiroyuki Arai; Nobuhisa Iwata; Takaomi Saido; Naomasa Yamamoto; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

Review 10.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.